Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01567943 · ClinicalTrials.gov registry record · NA

Contingency Management of Alcohol Abuse in the Severely Mentally ILL

A NA study of Schizophrenia and Major Depressive Disorder, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
123
Enrollment target
1
Study location

NCT01567943 is a NA study of Schizophrenia and Major Depressive Disorder that has completed, run by University of Washington. The registered enrollment target is 123 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01567943, a NA study of Schizophrenia and Major Depressive Disorder, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
123 participants
Enrollment target
1
Study location

Study Summary

The investigators will evaluate the efficacy of a comprehensive 12-week contingency management intervention for treating alcohol dependence for persons with severe mental illness who are seen within the context of a community mental health center setting. The primary contingency will be submission of alcohol-free urines. Additional reinforcers will be provided for intensive outpatient addiction treatment attendance. Reinforcers will be vouchers or actual items useful for day-to-day living. Participants will be 120 adults diagnosed with alcohol dependance and severe mental illness.

Interventions

  • BEHAVIORAL Contingency Management

Study Locations (1)

Washington

  • Harborview Medical Center - Seattle

Trial Details

FieldValue
Enrollment Target 123 participants
Start Date 2012-03
Est. Completion 2016-02
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT01567943

The ClinicalTrials.gov registry entry for NCT01567943 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (44% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Schizophrenia appearing as the primary indexed condition, and to 1 intervention - of which Contingency Management is the first listed.

NCT01567943 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT01567943 about?

NCT01567943 is a clinical study titled "Contingency Management of Alcohol Abuse in the Severely Mentally ILL". The investigators will evaluate the efficacy of a comprehensive 12-week contingency management intervention for treating alcohol dependence for persons with severe mental illness who are seen within the context of a community mental health center setting. The primary contingency will be submission o...

What is the current status of trial NCT01567943?

This trial is currently completed. It is a NA study. The enrollment target is 123 participants. The study started on 2012-03. Estimated completion is 2016-02.

What conditions does trial NCT01567943 study?

This clinical trial studies the following conditions: Schizophrenia, Major Depressive Disorder, Bipolar Disorder, Alcohol Abuse.

What interventions are being tested in trial NCT01567943?

The interventions under investigation include: Contingency Management (BEHAVIORAL).

Who is sponsoring clinical trial NCT01567943?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01567943 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.